Peer-reviewedCC BYCureus
Individualized and Platform-Designated Gene-Editing Studies in the Registered Clinical Record: A Case-by-Case Census Against 148 Eligible Studies
- 1Zweistein Innovation Lab, Active Care and Education in Sports and Outreach (ACESO) Foundation, Dublin, USA
Related
- Neuroscience-Informed Psychoeducation as a Digital, Individualized, and Adaptive Neurotechnology Platform
- Clinical, epidemiological, and economic profile of patients with Parkinson disease eligible for neuromodulation
- Fusion of Deep Learning Radiomics and Clinical Features for Individualized Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma
- Global clinical development of transcranial temporal interference stimulation: an analysis of registered human trials
- Changes in parent-rated attention-deficit/hyperactivity disorder symptom scores and sleep parameters during individualized multidisciplinary clinical management in children with comorbid obstructive sleep apnea: a prospective cohort study in Vietnam
BibTeX
@article{li2026individualized,
title = {{Individualized and Platform-Designated Gene-Editing Studies in the Registered Clinical Record: A Case-by-Case Census Against 148 Eligible Studies}},
author = {Oscar Mingtian Li and Yijiang Li},
journal = {Cureus},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13672691},
note = {CC BY},
}
RIS
TY - JOUR
TI - Individualized and Platform-Designated Gene-Editing Studies in the Registered Clinical Record: A Case-by-Case Census Against 148 Eligible Studies
AU - Oscar Mingtian Li
AU - Yijiang Li
PY - 2026
DA - 2026/10/19
JO - Cureus
UR - https://europepmc.org/article/PMC/PMC13672691
SN - 2168-8184
ER -